Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.

摘要: Objective To identify the geographic, organisational, and payment correlates of buprenorphine methadone treatment among substance abuse (SAT) providers. Methods Secondary analyses National Survey Substance Abuse Treatment Services (NSSATS) from 2007–16 were conducted. We provide bivariate descriptive statistics regarding services which offered 2007–16. Using multiple logistic regression, we regressed on treatment. Results Buprenorphine is increasingly at SAT facilities though uptake remains comparatively low outside northeast. run by tribal governments or Indian Health Service offer remain compared to privately operated (AOR = 0.528). The odds offering free no charge 0.838) a sliding fee scale 0.464) was lower. accepting Medicaid payments showed higher 2.035). Conclusions Greater attention towards disparities in provision opioid agonist therapies warranted, especially reasons why has been moderate civilian Additionally, care needs Native Americans facing opioid-related use disorders bears further scrutiny.